FTC Staff Comment Before the Missouri House of Representatives Regarding Missouri House Bills 1481 and 1491

us-ftc-advocacy-filings-c1095dbedd8ecffced68778ff8282886FTC Staff Comment Before the Missouri House of Representatives Regarding Missouri House Bills 1481 and 1491Advocacy Filing

Matter Number
V140009

Summary

Staff submitted a comment, in response to a request by Representative Jeanne Kirkton of the Missouri House of Representatives, regarding Missouri House Bills 1481 and 1491. HB 1491 would allow APRNs to assess and diagnose patients and order diagnostic and therapeutic tests and procedures, without a collaborative practice arrangement with a particular physician as required under existing Missouri law. HB 1481 would allow physicians and APRNs to collaborate electronically, replacing a law requiring their offices to be physically nearby. The staff comment stated that the bills would curtail costly barriers to competition that may deter procompetitive innovation in health care delivery. The comment referenced staff’s March 2014 policy paper, Policy Perspectives: Competition and the Regulation of Advanced Practice Registered Nurses, for support.
Page 1 of 7
UNITED STATES OF AMERICA
FEDERAL TRADE COMMISSION
WASHINGTON, D.C. 20580
Office of Policy Planning
Bureau of Economics
Bureau of Competition
May 5, 2014
Hon. Jeanne Kirkton
Missouri House of Representatives
State Capitol – Room 135BC
Jefferson City, MO 65101-6806
Dear Representative Kirkton:
The staffs of the Federal Trade Commission Office of Policy Planning, Bureau of
Economics, and Bureau of Competition1 appreciate the opportunity to respond to your invitation
for comments on Missouri House Bills 1481 and 1491 (“HB1481” and “HB1491,” respectively)
and their companion Missouri Senate Bills (collectively, “the Bills”). 2 The Bills would amend
certain statutory requirements for “collaborative practice arrangements” between Missouri
physicians and advanced practice registered nurses (“APRNs”). For the reasons discussed below,
we think the Bills offer several procompetitive and pro-consumer benefits.
The competitive implications of various types of APRN regulations, including mandatory
collaborative practice arrangements, were analyzed in the attached March 2014 FTC staff policy
paper. 3 As explained in the policy paper, FTC staff recognize the critical importance of patient
health and safety, and we defer to state legislators to survey the available evidence, determine the
optimal balance of policy priorities, and define the appropriate scope of practice for APRNs and
other health care providers. At the same time, we observe that undue regulatory restrictions on
APRN practice can impose significant competitive costs on health care consumers and other
payors. Hence, we have urged state legislators to avoid restrictions on APRN practice that do not
address well-founded patient safety concerns. “Based on substantial evidence and experience,
expert bodies have concluded that ARPNs are safe and effective as independent providers …
within the scope of their training, licensure, certification, and current practice.” 4 In particular, we
1 This letter expresses the views of the Federal Trade Commission's Office of Policy Planning, Bureau of
Economics, and Bureau of Competition. The letter does not necessarily represent the views of the Federal Trade
Commission (“Commission”) or of any individual Commissioner. The Commission has, however, voted to authorize
staff to submit these comments.
2 Letter from Hon. Jeanne Kirkton, Missouri House of Representatives, to Susan S. DeSanti, FTC Office of Policy
Planning (Feb. 18, 2014).
3 FED. T RADE COMM ’N STAFF, P OLICY P ERSPECTIVES: COMPETITION AND THE REGULATION OF ADVANCED P RACTICE
N URSES (2014), http://www.ftc.gov/system/files/documents/reports/policy-perspectives-competition-regulation-
advanced-practice-nurses/140307aprnpolicypaper.pdf [hereinafter FTC STAFF P OLICY P ERSPECTIVES].
4 Id. at 2.
Complete printed PDF page 1
Page 2 of 7
suggest that “[m]andatory . . . collaborative practice agreement requirements are likely to impede
competition among health care providers . . . leading to decreased access to health care services,
higher health care costs, reduced quality of care, and less innovation in health care delivery. 5
We hope you will keep these considerations in mind as you evaluate the Bills.
Discussion
I. 	HB1491
HB1491 would establish particular licensure requirements for APRNs, to be implemented
by the Board of Nursing. HB1491 also appears to provide that APRNs may, within the scope of
their practice and training, assess and diagnose patients, and order both diagnostic and
therapeutic tests and procedures, without obtaining a collaborative practice arrangement with a
particular physician. 6
Section III of the FTC staff policy paper discusses in detail the potential competitive
harms from overly restrictive APRN physician supervision requirements, and also identifies the
types of mandatory collaboration arrangements that often amount to de facto physician
supervision requirements.7 In brief, the policy paper suggests that:
1) 	supervision or “collaborative practice” requirements exacerbate well-documented
provider shortages that could be mitigated by expanding APRN practice;
2) 	such requirements may increase health care costs and prices;
3) 	rigid statutory requirements may needlessly constrain innovation in health care delivery;
and
4) 	such mandates do not appear necessary to achieve the benefits of coordinated care.
5 Id. at 37.
6 Within the scope of APRN practice, HB1491 would permit, among other things, “(a) Patient assessment that leads
to advanced diagnosis . . . ; (b) Ordering diagnostic and therapeutic tests and procedures; (c) Performing tests and
procedures within the scope of practice and interpreting and using results to further patient care; (d) Ordering
treatments consistent with specialty population training . . . and using nursing, medical, therapeutic, and corrective
measures to treat illness and improve health status; . . . and (g) Ordering appropriate medications in accordance with
prescriptive authority.” HB1491, Section A, amending M O. REV. STAT. § 335.016. Nothing in HB1491 requires that
an APRN enter into a collaborative practice agreement. HB1491 does stipulate a revision to M O. REV. STAT. §
335.019.2., such that “[a]ll licensed APRNs are authorized to: (1) Prescribe and institute medication therapy within
such APRN's practice and specialty ....” It is unclear, however, how this provision will be read in conjunction with
M O. REV. STAT. § 338.198, which could be read to require a collaborative practice agreement before a pharmacist
may fill a prescription from an APRN, notwithstanding other provisions of Missouri law.
7 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 18-38.
Complete printed PDF page 2
Page 3 of 7
First, the United States faces a substantial and growing shortage of physicians, especially
in primary care. 8 As a result, for many Americans, including some in Missouri, access to basic
health care services may be limited, especially in poor or rural areas. 9 According to the Missouri
Department of Health and Senior Services, “[h]ealth care resources in rural Missouri are limited,
even for those who have health insurance, have no financial difficulty, and have access to
transportation. . . . As regards access to primary health care services, the vast majority of rural
counties are designated as Health Professional Shortage Areas (HPSAs).” 10 Across the country,
APRNs already “make up a greater share of the primary care workforce in less densely populated
areas, less urban areas, and lower income areas, as well as in HPSAs.”11
Second, APRNs tend to provide care at lower cost than physicians when they are not
subject to unnecessary regulatory requirements. Maintaining undue legal or regulatory hurdles
may raise the costs of APRN services, reducing supply and further diminishing access to basic
primary care. Moreover, both patients and third-party payors are harmed to the extent that costs
are instead passed along as higher prices. 12 In contrast, when the regulatory costs of APRN
services decline (e.g., by removing particular collaborative practice requirements), the supply of
professionals willing to offer those services at any given price is likely to increase. In
underserved areas and for underserved populations, the benefits of expanding supply are clear:
consumers are likely to gain access to services that otherwise would be unavailable. 13 Even in
well-served areas, a supply expansion will tend to lower prices and drive down health care
costs. 14
Third, “rigid supervision [and collaborative arrangement] requirements may impede,
rather than foster, development of effective models of team-based care.” 15 Health care providers
that employ or contract with APRNs typically develop and implement their own practice
protocols, hierarchies of supervision, and models of team-based collaboration to promote quality
8 Id. at 20.
9 Id. at 21.
10 M ELISSA V AN D YNE ET AL., M ISSOURI D EP ’ T H EALTH AND SENIOR SERVS., H EALTH IN R URAL M ISSOURI:
B IENNIAL REPORT, 2012-2013, 4-5 (2014) (“Of the 101 rural counties, 98 are Primary Medical HPSAs.”).
11 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 25.
12 Id. at 27-28.
13 “Expanded APRN practice is widely regarded as a key strategy to alleviate provider shortages, especially in
primary care, in medically underserved areas, and for medically underserved populations.” Id. at 20 (citing, e.g.,
I NST. OF M ED., N AT ’ L ACAD. OF SCIENCES, T HE FUTURE OF N URSING: LEADING CHANGE , ADVANCING H EALTH 98-
103, 157- 61 annex 3-1 (2011) [hereinafter IOM FUTURE OF N URSING REPORT]; CHRISTINE E. E IBNER ET AL., RAND
H EALTH REPORT SUBMITTED TO THE C OMMONWEALTH OF M ASSACHUSETTS, CONTROLLING H EALTH C ARE
SPENDING IN M ASSACHUSETTS: AN ANALYSIS OF O PTIONS 99 (2009),
http://www.rand.org/content/dam/rand/pubs/technical_reports/2009/RAND_TR733.pdf; N AT ’ L G OVERNORS ASS’N,
NGA P APER : T HE ROLE OF N URSE P RACTITIONERS IN M EETING I NCREASING D EMAND FOR P RIMARY C ARE (2012),
http://www.nga.org/files/live/sites/NGA/files/pdf/1212NursePractitionersPaper.pdf [hereinafter NGA P RIMARY
C ARE P APER ]).
14 The National Governors Association recognized the impact of this supply expansion in its NGA P RIMARY C ARE
P APER , supra note 13.
15 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 34.
Complete printed PDF page 3
Page 4 of 7
of care, satisfy their business objectives, and comply with applicable regulatory requirements.
New models of collaboration represent an important form of innovation in health care delivery.
Proponents of team-based care have recognized the importance of this type of innovation, given
the myriad approaches to team-based care that may succeed in different practice settings. 16 Rigid
collaborative practice requirements “can arbitrarily constrain this type of innovation, as they can
impose limits or costs on new and beneficial collaborative arrangements, limit a provider’s
ability to accommodate staffing changes across central and satellite facilities or preclude some
provider strategies altogether.” 17
Fourth, we have seen no evidence that statutory collaborative practice agreement
requirements are necessary to achieve the benefits of team-based health care. On the contrary, as
noted above, rigid supervision and collaboration requirements may impede, rather than foster,
development of effective models of team-based care. 18 Collaboration between APRNs and
physicians is common in all states, including those that permit APRNs to practice without
mandatory collaborative practice agreements. 19 Most APRNs work for institutional providers or
physician practices, with established channels of collaboration and supervision, and even
“independently” practicing APRNs typically consult physicians and refer patients as
appropriate. 20 HB1491 would maintain state-level APRN oversight to ensure safe and
responsible practice within a variety of care delivery settings, including a requirement of
collaboration and referral to meet patients’ needs.
HB1491 appears consistent with FTC staff’s recommendation that state legislators avoid
imposing restrictions on APRN scope of practice, unless those restrictions are necessary to
address well-founded patient safety concerns. As noted above, “[b]ased on substantial evidence
and experience, expert bodies have concluded that ARPNs are safe and effective as independent
providers of many health care services within the scope of their training, licensure, certification,
and current practice.” 21
16 Id. at 31 (citing Pamela Mitchell et al., Nat’l Acad. of Sciences, Inst. of Med. Discussion Paper, Core Principles
& Values of Effective Team-Based Health Care (2012), http://www.iom.edu/~/media/Files/Perspectives-Files/2012/
Discussion-Papers/VSRT-Team-Based-Care-Principles-Values.pdf (IOM-sponsored inquiry into collaborative or
team-based care)).
17 Id. at 32.
18 Id. at 34 (citing I NST. OF M ED ., N AT ’ L ACAD. OF SCIENCES, D ELIVERING H IGH Q UALITY C ANCER CARE : CHARTING
A N EW COURSE FOR A SYSTEM IN CRISIS, 171-81 (2013) (discussing importance of and different approaches to team-
based care in cancer treatment, and roles of APRNs)). Regarding the evolution and diversity of team-based care, see
generally, Pamela Mitchell et al., Nat’l Acad. of Sciences, Inst. of Med. Discussion Paper, Core Principles & Values
of Effective Team-Based Health Care (2012), http://www.iom.edu/~/media/Files/Perspectives-Files/2012/
Discussion-Papers/VSRT-Team-Based-Care-Principles-Values.pdf.
19 Regarding diverse practice settings and collaboration, see IOM FUTURE OF N URSING REPORT, supra note 13, at 23,
58-59, 65-67, 72-76; see generally Mitchell et al., supra note 18.
20 A report by the Robert Wood Johnson Foundation describes several private and public models of innovative ways
to use APRNs in team-based care. ROBERT W OOD J OHNSON FOUND., H OW N URSES ARE SOLVING S OME OF P RIMARY
C ARE ’S M OST P RESSING CHALLENGES (2012), http://www.rwjf.org/content/dam/files/rwjf-web-files/
Resources/2/cnf20120810.pdf.
21 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 3 (citing, e.g., IOM FUTURE OF N URSING REPORT, supra note
13, at 98-99; NGA P RIMARY C ARE P APER , supra note 13, at 7-8; E IBNER ET AL., RAND H EALTH REPORT, supra note
13).
Complete printed PDF page 4
Page 5 of 7
II. 	HB1481
HB1481 amends several of Missouri’s current requirements for collaborative
practice arrangements. In particular, HB1481 permits “effective electronic collaboration”
between an APRN and a physician, instead of stipulating a particular physical distance
between them; and HB1481 permits a collaborating physician to review an APRN’s
records via electronic chart review. 22 We see several potential benefits of HB1481 with
respect to innovation in the adoption of health information technology, although we note
that HB1481 would operate within the confines of mandatory collaborative practice
arrangements, about which we have raised significant competitive concerns. It is
therefore likely to be less beneficial for competition and consumers than HB1491.
Health information technology is expanding rapidly, and the development of new
models of basic care delivery (including retail clinics staffed primarily by APRNs)23
creates an even greater need to facilitate efficient exchanges of health information among
various health care providers. Effective electronic communication and chart review
represent the type of innovative response to developments in health care delivery that
FTC staff encourages in its policy paper. 24
It is also possible that HB1481 would lower the costs of the collaborative practice
arrangements now required under Missouri law. First, even established collaborations
might find it more efficient to carry out some of their communications and chart review
electronically, rather than in person. Second, by removing arbitrary geographic
constraints on collaboration agreements, HB1481 may facilitate competition in
collaboration, permitting APRNs and physicians to form more effective and efficient
collaboration agreements.25 Regarding the types of geographic limits addressed in
HB1481, the policy paper notes:
FTC staff have seen some evidence that the costs of collaborative practice
agreements, including prices paid by APRNs to physicians, may be especially
high in markets exhibiting certain characteristics. For example, APRNs may find
it particularly difficult to form such contracts in rural or other underserved areas
where collaborating physicians are in short supply.26
22 HB1481, amending M O. REV. STAT. § 334.104.3.
23 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 33.
24 Id. at 3-4.
25 “[R]estrictions on the permissible physical distance between APRNs and supervising doctors may restrict
providers’ ability to develop new models of networked or telemedicine-facilitated collaboration.” FTC STAFF
P OLICY P ERSPECTIVES, supra note 3, at 32-33 (citing Comment from FTC Staff to the Hon. Daphne Campbell, Fla.
House of Representatives (Mar. 22, 2011), http://www.ftc.gov/os/2011/03/V110004campbell-florida.pdf; M O. CODE
REGS. ANN. tit. 20 § 2150-5.100 (2) (A)-(B)).
26 FTC STAFF P OLICY P ERSPECTIVES, supra note 3, at 30.
Complete printed PDF page 5
Page 6 of 7
Permitting effective electronic collaboration without arbitrary distance limits may help
alleviate this problem in Missouri, as APRNs and physicians would be able to bypass
local shortages and look elsewhere in the state for effective, and competitively priced,
collaborators.
Conclusion
To promote competition in health care markets, it may be important to scrutinize
relevant safety and quality evidence to determine whether or where legitimate safety
concerns exist and, if so, whether mandatory collaborative practice requirements are
likely to address them. To that end, FTC staff have looked to the findings of the Institute
of Medicine and other expert bodies on issues of APRN safety, effectiveness, and
efficiency. Based on their findings and our own reviews of pertinent literature,
mandatory collaborative practice agreements do not appear to be justified by legitimate
health and safety concerns, which is why we believe HB1491 may offer significant
benefits for Missouri health care consumers. We hope you will carefully consider this
body of research when considering whether there is adequate countervailing evidence to
justify maintaining Missouri’s current collaborative practice requirements.
Further, we hope you will consider that both HB1491 and 1481 would eliminate
statutory requirements that may impose substantial competitive costs on health care
providers and deter procompetitive innovation in health care delivery, to the ultimate
detriment of Missouri health care consumers, as well as both public and private third-
party payors.
We appreciate your consideration of these issues, and we hope the attached FTC staff
policy paper will be helpful in your deliberations.
Complete printed PDF page 6
Page 7 of 7
Respectfully submitted,
Andrew I. Gavil
Director
Office of Policy Planning
Martin S. Gaynor
Director
Bureau of Economics
Deborah Feinstein
Director
Bureau of Competition
Complete printed PDF page 7

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.